Abbott i-STAT CG8+, EG7+, EG6+ Cartridges Recalled in 2025 Over Missing 510(k) Clearance
Abbott Point Of Care recalled 547,250 i-STAT CG8+, EG7+, and EG6+ cartridges distributed nationwide in the United States. The recall concerns lack of 510(k) premarket clearance for updated sample types and measurement ranges. Hospitals and clinicians should stop using these cartridges immediately and follow Abbott’s recall instructions.
Quick Facts at a Glance
Recall Date
August 21, 2025
Hazard Level
HIGH
Brand
Abbott Point Of Care
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Abbott Point Of Care Inc. or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The i-STAT system uses disposable cartridges for point-of-care blood analysis in clinical settings. These cartridges are used with portable analyzers to rapidly measure various analytes and blood gas parameters.
Why This Is Dangerous
The hazard stems from the lack of regulatory clearance for updated cartridge types and measurement ranges. This could lead to regulatory noncompliance and potential uncertainty in diagnostic results.
Industry Context
This recall is not described as part of a broader industry pattern.
Real-World Impact
Hospitals and clinics may need to halt use of these cartridges, potentially affecting testing workflows and requiring regulatory coordination.
Practical Guidance
How to identify if yours is affected
Identify List Number 03P77-25 on cartridge packaging.
Confirm the cartridge lot numbers in inventory match those included in the recall.
Consult Abbott Point Of Care for clearance status before reuse.
Where to find product info
Refer to the recall notice and Abbott communications for identification codes beyond List Number 03P77-25.
What timeline to expect
Remediation timelines are set by Abbott and regulators; expect guidance to be issued by the manufacturer.
If the manufacturer is unresponsive
Escalate to hospital compliance or risk management offices.
File a formal inquiry with Abbott Point Of Care if responses are slow.
How to prevent similar issues
Verify regulatory clearance for new cartridge updates before stocking or using.
Implement supplier communications to capture regulatory status on new lots.
Document all recall communications and actions taken.
Documentation advice
Record lot numbers, List Number 03P77-25, dates of inventory, communications with Abbott, and internal decisions regarding use or disposal.
Product Details
Model numbers: List Number 03P77-25. All lot numbers. Distribution: US nationwide. Sold since: Unknown. Price: Unknown.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
547,250 units recalled
Lack of 510(k) clearance for updates to CG8+, EG7+, EG6+ cartridges
US nationwide distribution
Active recall as of 2025-08-21; FDA enforcement notice updated 2025-09-24
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.